Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA Would Get Funding Boost Under House Coronavirus Stimulus Bill

Executive Summary

Agency appears to have a fair bit of flexibility in how to spend the additional $80m slated for coronavirus activities.

You may also be interested in...



As Chloroquine Demand Surges, Bayer Looks To Emergency Use Authorization To Enter US Market

Unlike diagnostics, EUAs for drugs are rare and the fact that there already are FDA-approved competitors for Bayer’s chloroquine phosphate product may make the decision more complicated.

US FDA Commissioner Tries To Allay Concerns About Inspection Postponements

Screenings at ports of entry may be modified, but the drug supply remains safe and secure, Stephen Hahn tells House Committee, arguing that other tools will allow for continued facility policing during the coronavirus outbreak even if the absence of inspections.

Coronavirus Surveillance Expected To Rely On Existing Flu Network Without Much Strain

US CDC influenza official says that capacity is not an issue, since the system is already scaled for a pandemic, but a key will be availability of testing to distinguish the viruses.

Related Content

Topics

UsernamePublicRestriction

Register

PS141919

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel